Phase 2 Papulopustular Rosacea Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
Papulopustular Rosacea
Novartis Pharmaceuticals80 enrolled1 locationNCT07681271
Recruiting
Phase 2
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Narrows Institute for Biomedical Research20 enrolled1 locationNCT06952517